Eagle Strategies’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$275K Sell
2,920
-49
-2% -$4.67K 0.03% 243
2026
Q2
$251K Buy
2,969
+22
+0.7% +$1.77K 0.03% 253
2026
Q1
$208K Buy
2,947
+206
+8% +$15.4K 0.02% 251
2025
Q4
$216K Buy
2,741
+38
+1% +$3.01K 0.03% 240
2025
Q3
$223K Buy
2,703
+16
+0.6% +$1.26K 0.03% 229
2025
Q2
$216K Buy
2,687
+109
+4% +$8.41K 0.03% 217
2025
Q1
$207K Sell
2,578
-129
-5% -$10.7K 0.04% 209
2024
Q4
$222K Buy
2,707
+123
+5% +$10.2K 0.04% 205
2024
Q3
$213K Buy
+2,584
New +$193K 0.04% 202

Other funds holding MET

Eagle Strategies's MET Position: Q3 2026 in Review

Eagle Strategies reduced its MetLife (MET) stake by 1.7% in Q3 2026, selling an estimated $4.67K and leaving 2,920 shares worth $275K. The position accounts for 0.03% of the portfolio, ranked #243.

Eagle Strategies first reported a position in MET in Q3 2024 and has held it in 9 quarters since. 1,524 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Eagle Strategies held 2,920 shares of MetLife worth $275K as of Q3 2026.
  • Eagle Strategies sold 49 MetLife shares in Q3 2026, an estimated $4.67K.
  • MetLife made up 0.03% of Eagle Strategies's portfolio in Q3 2026, its #243 holding.
  • Eagle Strategies first reported a position in MetLife in Q3 2024 and has held it in 9 quarters since.
  • 1,524 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Eagle Strategies's 13F filing for Q3 2026, filed 16 Oct 2026.